SyntheticMR’s software solution for MR imaging, SyMRI NEURO, enables more efficient workflows and supports more precise diagnosis of patients. Philips currently offers the quantitative MR sequence SyntAc as an option to their customers, which in combination with SyntheticMR’s software solution generates multiple contrast-weighted images and volumetric measurements of brain tissue in a single 5-6 minute scan. With this new agreement in place, Philips will now have a streamlined path to provide the complete package SyntAc and SyMRI NEURO to their customers. SyMRI NEURO is already sold by Philips in the US under a regional sales agreement. SyMRI NEURO is compatible with most Philips MRI scanners.

“Philips is an important partner to SyntheticMR and we have established a close collaboration since the first co-marketing agreement was signed in 2015,” says Ulrik Harrysson, CEO, SyntheticMR AB. “We believe this collaboration will greatly benefit clinicians by giving them easy access to a solution that can further enhance their efficiency, diagnostic confidence and monitoring of patients.”



About SyntheticMR AB
SyntheticMR AB develops and markets innovative software solutions for Magnetic Resonance Imaging (MRI). SyntheticMR AB has developed SyMRI®, delivering multiple, adjustable contrast images and quantitative data from a single 6-minute scan. The SyMRI product is available in different packages. SyMRI NEURO delivers multiple contrast images, tissue segmentations and quantitative data on the brain. SyMRI MSK provides multiple contrast images and quantitative data for MSK anatomies. SyMRI NEURO is CE-marked and FDA 510(k) cleared and SyMRI MSK is CE-marked and FDA 510(k) pending. SyMRI is a registered trademark in Europe and the USA. SyntheticMR is listed on the Spotlight Stock Market Exchange in Stockholm, Sweden.

Health IT Homepage